0001209191-17-002446.txt : 20170105
0001209191-17-002446.hdr.sgml : 20170105
20170105210732
ACCESSION NUMBER: 0001209191-17-002446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170104
FILED AS OF DATE: 20170105
DATE AS OF CHANGE: 20170105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zeltiq Aesthetics Inc
CENTRAL INDEX KEY: 0001415336
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 270119051
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4698 Willow Road
STREET 2: Suite 100
CITY: Pleasanton
STATE: CA
ZIP: 94588-2710
BUSINESS PHONE: (925) 474-2500
MAIL ADDRESS:
STREET 1: 4698 Willow Road
STREET 2: Suite 100
CITY: Pleasanton
STATE: CA
ZIP: 94588-2710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Keith J
CENTRAL INDEX KEY: 0001417973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35318
FILM NUMBER: 17512703
MAIL ADDRESS:
STREET 1: C/O RELIANT TECHNOLOGIES, INC.
STREET 2: 464 ELLIS STREET
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-04
0
0001415336
Zeltiq Aesthetics Inc
ZLTQ
0001417973
Sullivan Keith J
C/O ZELTIQ AESTHETICS, INC.
4410 ROSEWOOD DRIVE
PLEASANTON
CA
94588
0
1
0
0
CCO, President, North America
Common Stock
2017-01-04
4
M
0
8000
6.21
A
87198
D
Common Stock
2017-01-04
4
S
0
7700
44.3367
D
79498
D
Common Stock
2017-01-04
4
S
0
100
44.89
D
79398
D
Common Stock
2017-01-04
4
S
0
100
44.90
D
79298
D
Common Stock
2017-01-04
4
S
0
100
44.91
D
79198
D
Common Stock
5000
I
By Keith J Sullivan (IRA) FCC as custodian
Stock Option (Right to Buy)
6.21
2017-01-04
4
M
0
8000
0.00
D
2022-10-04
Common Stock
8000
74000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer.
/s/ Sergio Garcia, Attorney-in-Fact
2017-01-05